Consensus $6.27. Raises FY25 revenue view to $3.04B-$3.06B from $2.95B-$2.98B, consensus $2.96B. Backs FY25 capital spending view $275M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WST:
- West Pharmaceutical reports Q2 adjusted EPS $1.84, consensus $1.51
- West Pharmaceutical Services, Inc. (WST) Q2 Earnings Cheat Sheet
- West Pharmaceutical Appoints New CFO Robert McMahon
- Strategic Leadership Change at West Pharmaceutical Services Boosts Buy Rating
- West Pharmaceutical appoints Robert McMahon as CFO